Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001746473-25-000091
Filing Date
2025-04-23
Accepted
2025-04-23 16:19:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a2025a.htm DEFA14A 13760
2 GRAPHIC a2025noticeofinternetava001.jpg GRAPHIC 157285
3 GRAPHIC a2025noticeofinternetava002.jpg GRAPHIC 118795
  Complete submission text file 0001746473-25-000091.txt   395210
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39303 | Film No.: 25861753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)